SMMT Shorts Ease as Earnings and FDA Decision Loom
Summit Therapeutics arrives at its October 27 earnings release with shorts quietly stepping back, options traders leaning toward calls, and a binary FDA decision on ivonescimab sitting just weeks beyond the print. The…